Microbiome-Specific Statistical Modeling Identifies Interplay Between Gastrointestinal Microbiome and Neurobehavioral Outcomes in Patients With Autism: A Case Control Study

Minshi Huang, Jun Liu, Kevin Liu, Jierong Chen, Zhen Wei, Zhe Feng, Yuyu Wu, Michelle Fong, Ruiyi Tian, Bryan Wang, Christoph Budjan, Patrick Zhuang, Guobin Wan, Xue-Jun Kong, Minshi Huang, Jun Liu, Kevin Liu, Jierong Chen, Zhen Wei, Zhe Feng, Yuyu Wu, Michelle Fong, Ruiyi Tian, Bryan Wang, Christoph Budjan, Patrick Zhuang, Guobin Wan, Xue-Jun Kong

Abstract

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with unclear mechanisms of pathogenesis. Gastrointestinal microbiome alterations were found to correlate with ASD core symptoms, but its specific role in ASD pathogenesis has not been determined. In this study, we used a case-control strategy that simultaneously compared the ASD gastrointestinal microbiome with that from age-sex matched controls and first-degree relative controls, using a statistical framework accounting for confounders such as age. Enterobacteriaceae (including Escherichia/Shigella) and Phyllobacterium were significantly enriched in the ASD group, with their relative abundances all following a pattern of ASD > first degree relative control > healthy control, consistent with our hypothesis of living environment and shared microbial and immunological exposures as key drivers of ASD gastrointestinal microbiome dysbiosis. Using multivariable omnibus testing, we identified clinical factors including ADOS scores, dietary habits, and gastrointestinal symptoms that covary with overall microbiome structure within the ASD cohort. A microbiome-specific multivariate modeling approach (MaAsLin2) demonstrated microbial taxa, such as Lachnoclostridium and Tyzzerella, are significantly associated with ASD core symptoms measured by ADOS. Finally, we identified alterations in predicted biological functions, including tryptophan and tyrosine biosynthesis/metabolism potentially relevant to the pathophysiology of the gut-brain-axis. Overall, our results identified gastrointestinal microbiome signature changes in patients with ASD, highlighted associations between gastrointestinal microbiome and clinical characteristics related to the gut-brain axis and identified contributors to the heterogeneity of gastrointestinal microbiome within the ASD population.

Keywords: autism spectrum disorder; biological pathway; gut microbiome; gut-brain axis; multivariable omnibus testing; predictive functional profiling.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Huang, Liu, Liu, Chen, Wei, Feng, Wu, Fong, Tian, Wang, Budjan, Zhuang, Wan and Kong.

Figures

Figure 1
Figure 1
Overview of groupwise subject gut microbiome ecological diversity and differentially enriched gut microbiota that are most prevalent in ASD group subjects, followed by healthy controls and first-degree relative controls, respectively. (A) Groupwise comparison of alpha diversity determined via Shannon index in all groups. (B) Alpha diversity via the Shannon index displays significant inverse correlation with ADOS overall score. (C) PCoA of species after filtering (Bray-Curtis) with 95% confidence ellipses. ASD microbiota showed (D) a lower abundance of Akkermansia but a higher abundance of (E) enterobacteriaceae, (F)phyllobacterium, (G)E. Shigella, and (H)E. coli when compared to first-degree relative controls and healthy controls.
Figure 2
Figure 2
The ASD gut microbiota displayed significant differences in predicted metabolic pathways when compared to healthy controls. (A) ASD microbiota expressed lower levels of D-Gln, D-Glu metabolism and higher levels of (B) Trp, (C) Tyr, and (D) fatty acid metabolism. (E) ASD microbiota displayed lower levels of Phe, Try, and Trp biosynthesis and (F) higher levels of Lys degradation. Significant indices were chosen at a Q-value cutoff of 0.1.
Figure 3
Figure 3
ASD severity was associated with gut microbiota abundance. (A) Stereotypic behavior was positively correlated to Tyzzerella relative abundance. (B–D,F–H) ADOS subscale scores (social affect, SA), total scores, and standard score (CSS) were correlated with relative abundance of bacterial taxa. (E) GI severity index score was positively associated with Butyricicoccus abundance. Indices were chosen at a univariate Q-value (FDR-adjusted P-value) cutoff of 0.1.

References

    1. Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, et al. . Prevalence of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Mmwr Surveillance Summ. (2018) 67:1–23. 10.15585/mmwr.ss6706a1
    1. Karimi P, Kamali E, Mousavi SM, Karahmadi M. Environmental factors influencing the risk of autism. J Res Med Sci. (2017) 22:27. 10.4103/1735-1995.200272
    1. Liu J, Zhang M, Kong X-J. Gut microbiome and autism: recent advances and future perspectives. N A J Med Sci. (2016) 9:104–115. 10.7156/najms.2016.0903104
    1. Wu M, Wu Y, Yu L, Liu J, Zhang M, Kong X, et al. . A survey of epidemiological studies and risk factors of ASD, with a focus on China. N A J Med Sci. (2017) 10:124–32. 10.7156/najms.2017.1003124
    1. Alam R, Abdolmaleky HM, Zhou J. Microbiome, inflammation, epigenetic alterations, and mental diseases. Am J Med Genet Part B Neuropsychiatr Genet. (2017) 174:651–60. 10.1002/ajmg.b.32567
    1. Bengmark S. Gut microbiota, immune development and function. Pharmacol Res. (2013) 69:87–113. 10.1016/j.phrs.2012.09.002
    1. Bruce-Keller AJ, Salbaum JM, Berthoud H-R. Harnessing gut microbes for mental health: getting from here to there. Biol Psychiat. (2018) 83:214–23. 10.1016/j.biopsych.2017.08.014
    1. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. (2012) 13:701–12. 10.1038/nrn3346
    1. Peterson BS, Leckman JF, Tucker D, Scahill L, Staib L, Zhang H, et al. . Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders. Arch Gen Psychiat. (2000) 57:364–72. 10.1001/archpsyc.57.4.364
    1. Vuong HE, Hsiao EY. Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiat. (2017) 81:411–23. 10.1016/j.biopsych.2016.08.024
    1. Kong X, Liu J, Cetinbas M, Sadreyev R, Koh M, Huang H, et al. . New and preliminary evidence on altered oral and gut microbiota in individuals with autism spectrum disorder (ASD): implications for ASD diagnosis and subtyping based on microbial biomarkers. Nutrients. (2019) 11:2128. 10.3390/nu11092128
    1. Luna RA, Oezguen N, Balderas M, Venkatachalam A, Runge JK, Versalovic J, et al. . Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder. Cell Mol Gastroenterol Hepatol. (2017) 3:218–30. 10.1016/j.jcmgh.2016.11.008
    1. Plaza-Díaz J, Gómez-Fernández A, Chueca N, Torre-Aguilar MJ de la, Gil Á, Perez-Navero JL, et al. . Autism spectrum disorder (ASD) with and without mental regression is associated with changes in the fecal microbiota. Nutrients. (2019) 11:337. 10.3390/nu11020337
    1. Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, AL-Ayadhi LY, Alotaibi MR, et al. . Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children. Mol Immunol. (2019) 106:77–86. 10.1016/j.molimm.2018.12.020
    1. Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, AL-Ayadhi LY, Attia SM. Elevated IL-16 expression is associated with development of immune dysfunction in children with autism. Psychopharmacology. (2019) 236:831–8. 10.1007/s00213-018-5120-4
    1. Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Mohammad R, Attia SM. Immune alterations in CD8+ T cells are associated with neuronal C-C and C-X-C chemokine receptor regulation through adenosine A2A receptor signaling in a BTBR T+ Itpr3tf/J autistic mouse model. Mol Neurobiol. (2018) 55:2603–16. 10.1007/s12035-017-0548-9
    1. Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. . Environment dominates over host genetics in shaping human gut microbiota. Nature. (2018) 555:210–5. 10.1038/nature25973
    1. Picard RW, Devinsky O, Dworetzky B, French JA, Friedman D, Lai M, et al. . The importance of measuring autonomic data in new epilepsy treatments. Epilepsy Behav. (2015) 46:54–5. 10.1016/j.yebeh.2015.02.053
    1. Rodríguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al. . The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health D. (2015) 26:26050. 10.3402/mehd.v26.26050
    1. Ding HT, Taur Y, Walkup JT. Gut microbiota and autism: key concepts and findings. J Autism Dev Disord. (2016) 47:480–9. 10.1007/s10803-016-2960-9
    1. Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, et al. . Multivariable association discovery in population-scale meta-omics studies. Biorxiv [Preprint]. (2021). 10.1101/2021.01.20.427420
    1. Beijing Mental Development Cooperative Group . Gesell Developmental Diagnosis Scale. Beijing: Beijing Mental Development Cooperative Group; (1985).
    1. Rust JO, Wallace MA. Book review: adaptive behavior assessment system-second edition. J Psychoeduc Assess. (2004) 22:367–73. 10.1177/073428290402200407
    1. Vaughan S, McGlone F, Poole H, Moore DJ. A quantitative sensory testing approach to pain in autism spectrum disorders. J Autism Dev Disord. (2020) 50:1607–20. 10.1007/s10803-019-03918-0
    1. Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC, et al. . The autism diagnostic observation schedule—generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. (2000) 30:205–23. 10.1023/A:1005592401947
    1. Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. (2009) 39:693–705. 10.1007/s10803-008-0674-3
    1. Gau S-F. Chinese Version of the Autism Diagnostic Observation Schedule. New Taipei: Psychological Publishing Co. Ltd. (2001).
    1. Bourreau Y, Roux S, Gomot M, Bonnet-Brilhault F, Barthélémy C. Validation of the repetitive and restricted behaviour scale in autism spectrum disorders. Eur Child Adoles Psy. (2009) 18:675. 10.1007/s00787-009-0028-5
    1. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. (2013) 8:e61217. 10.1371/journal.pone.0061217
    1. Constantinno J, Gruber C. The Social Responsiveness Scale. Los Angeles, CA: Western Psychological Services; (2002).
    1. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. (2016) 13:581–3. 10.1038/nmeth.3869
    1. McIver LJ, Abu-Ali G, Franzosa EA, Schwager R, Morgan XC, Waldron L, et al. . bioBakery: a meta'omic analysis environment. Bioinform Oxf Engl. (2017) 34:1235–7. 10.1093/bioinformatics/btx754
    1. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. . Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. (2011) 7:539. 10.1038/msb.2011.75
    1. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. . The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. (2013) 41:D590–6. 10.1093/nar/gks1219
    1. Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. . Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. (2013) 31:814–21. 10.1038/nbt.2676
    1. Strati F, Cavalieri D, Albanese D, Felice CD, Donati C, Hayek J, et al. . New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. (2017) 5:24. 10.1186/s40168-017-0242-1
    1. Liu F, Li J, Wu F, Zheng H, Peng Q, Zhou H. Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review. Transl Psychiat. (2019) 9:43. 10.1038/s41398-019-0389-6
    1. Geerlings SY, Kostopoulos I, Vos WM de, Belzer C. Akkermansia muciniphila in the human gastrointestinal tract: when, where, and how? Microorg. (2018) 6:75. 10.3390/microorganisms6030075
    1. Xu M, Xu X, Li J, Li F. Association between gut microbiota and autism spectrum disorder: a systematic review and meta-analysis. Front Psychiatry. (2019) 10:473. 10.3389/fpsyt.2019.00473
    1. Kulkarni S, Ganz J, Bayrer J, Becker L, Bogunovic M, Rao M. Advances in enteric neurobiology: the “brain” in the gut in health and disease. J Neurosci. (2018) 38:9346–54. 10.1523/JNEUROSCI.1663-18.2018
    1. Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, AL-Ayadhi LY, Attia SM. Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children. Prog Neuropsychopharmacol Biol Psychiatry. (2018) 85:98–104. 10.1016/j.pnpbp.2018.04.011
    1. Alhosaini K, Ansari MA, Nadeem A, Attia SM, Bakheet SA, Al-Ayadhi LY, et al. . Dysregulation of Ki-67 expression in T cells of children with autism spectrum disorder. Children. (2021) 8:116. 10.3390/children8020116
    1. Neuhaus E, Bernier RA, Tham SW, Webb SJ. Gastrointestinal and psychiatric symptoms among children and adolescents with autism spectrum disorder. Front Psychiatry. (2018) 9:515. 10.3389/fpsyt.2018.00515
    1. Mancabelli L, Milani C, Lugli GA, Turroni F, Cocconi D, Sinderen D van, et al. . Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. Fems Microbiol Ecol. (2017) 93: fix153. 10.1093/femsec/fix153
    1. Stanislawski MA, Dabelea D, Lange LA, Wagner BD, Lozupone CA. Gut microbiota phenotypes of obesity. Npj Biofilms Microbiomes. (2019) 5:18. 10.1038/s41522-019-0091-8
    1. Mayer EA, Padua D, Tillisch K. Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioessays. (2014) 36:933–9. 10.1002/bies.201400075
    1. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther. (2015) 37:984–95. 10.1016/j.clinthera.2015.04.002
    1. Kong X, Liu J, Liu K, Koh M, Tian R, Hobbie C, et al. . Altered autonomic functions and gut microbiome in individuals with autism spectrum disorder (ASD): implications for assisting ASD screening and diagnosis. J Autism Dev Disord. (2020) 51:144–57. 10.1007/s10803-020-04524-1
    1. Hyland NP, Cryan JF. Microbe-host interactions: influence of the gut microbiota on the enteric nervous system. Dev Biol. (2016) 417:182–7. 10.1016/j.ydbio.2016.06.027
    1. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. . Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. (2013) 155:1451–63. 10.1016/j.cell.2013.11.024
    1. Sgritta M, Dooling SW, Buffington SA, Momin EN, Francis MB, Britton RA, et al. . Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron. (2018) 101:246–59.e6. 10.1016/j.neuron.2018.11.018
    1. Rodriguez-Castaño GP, Caro-Quintero A, Reyes A, Lizcano F. Advances in gut microbiome research, opening new strategies to cope with a western lifestyle. Front Genet. (2017) 7:224. 10.3389/fgene.2016.00224
    1. Rekdal VM, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. (2019) 364:eaau6323. 10.1126/science.aau6323
    1. Wang M, Wan J, Rong H, He F, Wang H, Zhou J, et al. . Alterations in gut glutamate metabolism associated with changes in gut microbiota composition in children with autism spectrum disorder. Msystems. (2019) 4:e00321–18. 10.1128/mSystems.00321-18
    1. Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. (2018) 9:3294. 10.1038/s41467-018-05470-4
    1. Gevi F, Zolla L, Gabriele S, Persico AM. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol Autism. (2016) 7:47. 10.1186/s13229-016-0109-5
    1. Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, et al. . Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Mi. (2018) 8:13. 10.3389/fcimb.2018.00013
    1. Szelest M, Walczak K, Plech T. A new insight into the potential role of tryptophan-derived AhR ligands in skin physiological and pathological processes. Int J Mol Sci. (2021) 22:1104. 10.3390/ijms22031104

Source: PubMed

3
Sottoscrivi